glp 1 and resting heart rate Retatrutide rate: what the clinical data actually shows Heart and health behavior responses

1 A separate variant in the GIPR gene predicts nausea and vomiting specifically in people taking tirzepatide (Mounjaro and Zepbound), but not in people taking semaglutide (Wegovy and Ozempic)

The Directions Groups own 2024 Integrated Intelligence Study of Life and Health Behaviors shows us that the consumers most likely to try GLP-1s for weight loss are Millennials and Gen X, women, and those in a higher income category

The difference between the two therapeutic approaches is the continuous chronic secretion of leptin mediated by gene delivery versus the intermittent bolus delivery and rapid clearance of daily injection of rh-leptin protein (Morsy et al., 1998)

Develop mindful eating practices: Eat without distractions and pay attention to hunger cues